Baird Medical Expands Global Microwave Ablation Technology Footprint with New Market Launches
Key Insights
Baird Medical successfully launched its minimally invasive Microwave Ablation (MWA) technology at Bakersfield Memorial Hospital (search) in California, marking the first ablation case for benign thyroid tumors (search) in the San Joaquin Valley region.
The company secured regulatory approvals from Pakistan's Medical Device Board and Vietnam's Ministry of Health, expanding its compliant footprint in Southeast Asian markets.
Dr. Tim Beck performed the inaugural procedure at Bakersfield Memorial, demonstrating the system's high-efficiency ablation capabilities and favorable safety profile in a high-volume hospital setting.
Baird Medical Investment Holdings Ltd (search) has achieved significant milestones in its global expansion strategy, successfully launching its minimally invasive Microwave Ablation (MWA) technology at Bakersfield Memorial Hospital (search) in California while securing regulatory approvals in Pakistan and Vietnam.
Strategic US Market Penetration
The deployment at Bakersfield Memorial Hospital (search) represents the first ablation case for benign thyroid tumors (search) in the vital central California hub of the San Joaquin Valley. Dr. Tim Beck, MD, a distinguished endocrine surgeon at Dignity Health Medical Group (search), successfully performed the inaugural procedure using Baird Medical's proprietary platform.
"The procedure demonstrated the system's high-efficiency ablation capabilities and favourable safety profile, validating the technology's value in a high-volume hospital setting," according to the company's announcement. This launch represents a focused execution of Baird Medical's commercial roadmap, aimed at equipping institutions with next-generation tools to enhance the standard of care for patients.
International Regulatory Milestones
Baird Medical has reached key regulatory milestones with official product registrations from both the Medical Device Board (MDB) of Pakistan and the Ministry of Health of Vietnam. In Pakistan, the company successfully executed its official product launch at the Armed Forces Institute of Radiology & Imaging (search) (AFIRI) under the professional guidance of Dr. Raza Raheem, a leading authority in the country's interventional radiology sector.
The registration approval in Vietnam marks a significant expansion of Baird Medical's compliant footprint within the Southeast Asian market. "Securing these approvals in Pakistan and Vietnam is a pivotal step in our international expansion," said Mrs. Haimei Wu, Chairwoman of Baird Medical. "By entering these high-growth markets, we are empowering local clinicians with advanced, minimally invasive tools to improve outcomes for patients."
Company Profile and Market Position
As a US FDA 510(k)-certified medical device company, Baird Medical's solutions have been used in over 30 prestigious hospitals and clinics across the United States, including Mayo Clinic, Tulane Medical Center, Columbia University Medical Center, UCSF Medical Center, Weill Cornell Medical Center, and The George Washington University Hospital.
The company holds market leadership in China for thyroid microwave ablation devices and consumables, while its minimally invasive treatment products are gradually expanding their commercial presence in over 20 countries worldwide. Baird Medical specializes in minimally invasive diagnostics and treatment, with dedication to the research and development of surgical robotic systems and innovative minimally invasive surgical instruments.
The company's mission extends beyond surgical assistance, aiming to develop intelligent systems that proactively guide diagnostic decisions and preventive healthcare strategies through strategic collaborations with leading academic institutions.